BR9307337A - Processo para tratamento de doença cardiovascular e supressão da expressão vcam-1 e composição farmacêutica - Google Patents
Processo para tratamento de doença cardiovascular e supressão da expressão vcam-1 e composição farmacêuticaInfo
- Publication number
- BR9307337A BR9307337A BR9307337A BR9307337A BR9307337A BR 9307337 A BR9307337 A BR 9307337A BR 9307337 A BR9307337 A BR 9307337A BR 9307337 A BR9307337 A BR 9307337A BR 9307337 A BR9307337 A BR 9307337A
- Authority
- BR
- Brazil
- Prior art keywords
- vcam
- treatment
- cardiovascular disease
- expression
- suppression
- Prior art date
Links
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 title abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 238000002399 angioplasty Methods 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 239000012990 dithiocarbamate Substances 0.000 abstract 1
- 150000004659 dithiocarbamates Chemical class 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/969,934 US5380747A (en) | 1992-10-30 | 1992-10-30 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
PCT/US1993/010496 WO1994009772A1 (en) | 1992-10-30 | 1993-11-01 | Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9307337A true BR9307337A (pt) | 1999-05-25 |
Family
ID=25516198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9307337A BR9307337A (pt) | 1992-10-30 | 1993-11-01 | Processo para tratamento de doença cardiovascular e supressão da expressão vcam-1 e composição farmacêutica |
Country Status (19)
Country | Link |
---|---|
US (2) | US5380747A (pt) |
EP (1) | EP0666741B1 (pt) |
JP (1) | JP3254486B2 (pt) |
AT (1) | ATE183089T1 (pt) |
AU (1) | AU692426B2 (pt) |
BG (1) | BG62682B1 (pt) |
BR (1) | BR9307337A (pt) |
CA (1) | CA2147881C (pt) |
CZ (1) | CZ111595A3 (pt) |
DE (1) | DE69326014T2 (pt) |
DK (1) | DK0666741T3 (pt) |
ES (1) | ES2136186T3 (pt) |
GR (1) | GR3031368T3 (pt) |
HU (1) | HUT73440A (pt) |
NO (1) | NO951616L (pt) |
NZ (1) | NZ258683A (pt) |
PL (1) | PL179113B1 (pt) |
SK (1) | SK56095A3 (pt) |
WO (1) | WO1994009772A1 (pt) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5821260A (en) * | 1992-10-30 | 1998-10-13 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5739115A (en) * | 1993-10-07 | 1998-04-14 | Glycomed Incorporated | Sulfated maltooligosaccharides with heparin-like properties |
US5677291A (en) * | 1993-12-10 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
DE69535063T2 (de) * | 1994-11-30 | 2006-12-21 | Nippon Chemiphar Co. Ltd. | Denaturierter low-density lipoprotein (ldl) rezeptor |
US20020040008A1 (en) * | 1995-01-24 | 2002-04-04 | Wagner Denisa D. | Method for treating and preventing atherosclerosis |
US6469057B1 (en) * | 1995-06-02 | 2002-10-22 | Mcw Research Foundation, Inc. | Methods for in vivo reduction of free radical levels and compositions useful therefor |
US5741815A (en) * | 1995-06-02 | 1998-04-21 | Lai; Ching-San | Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
US5792787A (en) * | 1995-06-07 | 1998-08-11 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5747528A (en) * | 1996-02-21 | 1998-05-05 | Warner-Lambert Company | Chroman derivatives as anti-oxidants |
US5608095A (en) * | 1996-04-30 | 1997-03-04 | Hoechst Marion Roussel, Inc. | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
US5795876A (en) * | 1996-04-30 | 1998-08-18 | Hoechst Marion Rousssel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols |
JP2000509070A (ja) * | 1996-04-30 | 2000-07-18 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 2,6―ジアルキル―4―シリル―フェノールを使用して血管細胞接着分子―1を阻害する方法および慢性炎症性疾患を治療する方法 |
US5782740A (en) * | 1996-08-29 | 1998-07-21 | Advanced Cardiovascular Systems, Inc. | Radiation dose delivery catheter with reinforcing mandrel |
US5922761A (en) * | 1996-09-06 | 1999-07-13 | Medinox, Inc. | Methods for in vivo reduction of iron levels and compositions useful therefor |
SK66198A3 (en) * | 1996-09-20 | 1999-09-10 | Atherogenics Inc | Diagnostics for and mediators of inflammatory disorders |
US6114572A (en) * | 1996-11-20 | 2000-09-05 | Hoechst Marion Roussel, Inc. | Substituted phenols and thiophenols useful as antioxidant agents |
US6670398B2 (en) * | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
ES2283933T3 (es) * | 1997-05-14 | 2007-11-01 | Atherogenics, Inc. | Ester del acido succinico de probucol para la inhibicion de la expresion de vcam-1. |
US6210312B1 (en) | 1997-05-20 | 2001-04-03 | Advanced Cardiovascular Systems, Inc. | Catheter and guide wire assembly for delivery of a radiation source |
US6121463A (en) * | 1997-06-24 | 2000-09-19 | Hoechst Marion Roussel, Inc. | Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents |
US6133467A (en) * | 1997-06-25 | 2000-10-17 | Hoechst Marion Roussel, Inc. | 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol |
WO1999001118A2 (en) * | 1997-07-01 | 1999-01-14 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
AU2662899A (en) * | 1998-02-13 | 1999-08-30 | Medinox, Inc. | Methods for the controlled delivery of carbon disulfide for the treatment of inflammatory conditions |
US6224535B1 (en) | 1998-02-17 | 2001-05-01 | Advanced Cardiovascular Systems, Inc. | Radiation centering catheters |
US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US20030181495A1 (en) * | 1998-06-23 | 2003-09-25 | Medinox, Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US6596770B2 (en) | 2000-05-05 | 2003-07-22 | Medinox, Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
WO2000000192A1 (en) * | 1998-06-26 | 2000-01-06 | University Of Washington | INHIBITION OF NF-λB MEDIATED TISSUE INJURY USING DITHIOCARBAMATE DERIVATIVES |
US6555579B2 (en) | 1998-08-13 | 2003-04-29 | The Wistar Institute | Methods for reducing atherosclerotic plaques |
US6589987B2 (en) | 1998-09-08 | 2003-07-08 | Charlotte-Mecklenburg Hospital Authority | Method of treating cancer using tetraethyl thiuram disulfide |
US7816403B2 (en) * | 1998-09-08 | 2010-10-19 | University Of Utah Research Foundation | Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same |
US6548540B2 (en) | 1998-09-08 | 2003-04-15 | Charlotte-Mecklenburg Hospital Authority | Method of treating cancer using dithiocarbamate derivatives |
US6706759B1 (en) | 1998-09-08 | 2004-03-16 | Charlotte-Mecklenburg Hospital Authority | Method of treating cancer using dithiocarbamate derivatives |
US6887712B1 (en) | 1998-11-09 | 2005-05-03 | Atherogenics, Inc. | Methods and compositions to lower plasma cholesterol levels |
US6372187B1 (en) | 1998-12-07 | 2002-04-16 | Mcdermott Technology, Inc. | Alkaline sorbent injection for mercury control |
US6284199B1 (en) * | 1999-03-31 | 2001-09-04 | Mcdermott Technology, Inc. | Apparatus for control of mercury |
US6855859B2 (en) * | 1999-03-31 | 2005-02-15 | The Babcock & Wilcox Company | Method for controlling elemental mercury emissions |
US6734192B1 (en) | 1999-08-23 | 2004-05-11 | Mp-1 Inc. | Treatment of viral infections |
US6582417B1 (en) | 1999-09-22 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Methods and apparatuses for radiation treatment |
US6605031B1 (en) | 1999-09-22 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stepped centering balloon for optimal radiation delivery |
US20030130185A1 (en) * | 2000-09-29 | 2003-07-10 | David Bar-Or | Metal-binding compounds and uses therefor |
KR101312880B1 (ko) | 1999-10-01 | 2013-09-30 | 디엠아이 바이오사이언시스, 인크 | 금속 결합 화합물 및 그의 용도 |
US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US20030158111A1 (en) * | 1999-10-01 | 2003-08-21 | David Bar-Or | Methods and products for oral care |
US7592304B2 (en) * | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US6274627B1 (en) | 1999-10-12 | 2001-08-14 | Medinox, Inc. | Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor |
CA2396165C (en) * | 2000-01-14 | 2011-01-04 | John F. Hunt | Airway alkalinization as therapy for airway diseases |
US6540734B1 (en) | 2000-02-16 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Multi-lumen extrusion tubing |
US7994449B2 (en) | 2000-02-16 | 2011-08-09 | Advanced Cardiovascular Systems, Inc. | Square-wave laser bonding |
US6710086B1 (en) | 2000-02-25 | 2004-03-23 | Medinox, Inc. | Protected forms of pharmacologically active agents and uses therefor |
US6747061B2 (en) | 2000-03-21 | 2004-06-08 | Atherogenics, Inc. | N-substituted dithiocarbamates for the treatment of biological disorders |
WO2002040021A2 (en) | 2000-11-17 | 2002-05-23 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
US7481790B2 (en) * | 2000-12-27 | 2009-01-27 | Advanced Cardiovascular Systems, Inc. | Vessel enlargement by arteriogenic factor delivery |
US20020168396A1 (en) * | 2001-02-22 | 2002-11-14 | Ramanan Ramaswami | Vasodilator impregnated devices and methods |
CA2458622A1 (en) * | 2001-08-24 | 2003-03-06 | Maine Medical Center Research Institute | Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
EP1450787A4 (en) | 2001-11-15 | 2006-01-25 | Galileo Pharmaceuticals Inc | FORMULATIONS AND METHODS FOR THE TREATMENT OR AMELIORATION OF INFLAMMATORY CONDITIONS |
MXPA04005864A (es) * | 2001-12-19 | 2004-10-29 | Atherogenics Inc | Derivados de charcona y su uso para tratar enfermedades. |
CA2493544A1 (en) * | 2002-07-22 | 2004-01-29 | Chemgenex Pharmaceuticals, Inc. | Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
DE10252772A1 (de) * | 2002-11-13 | 2004-05-27 | Beiersdorf Ag | Verwendung von einem oder mehreren Diethyldithiocarbamaten zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut |
US20040181075A1 (en) * | 2002-12-19 | 2004-09-16 | Weingarten M. David | Process of making chalcone derivatives |
SG142207A1 (en) * | 2003-01-13 | 2008-05-28 | Atherogenics Inc | Process of preparing esters and ethers of probucol and derivatives thereof |
WO2004108094A2 (en) * | 2003-06-06 | 2004-12-16 | Atherogenics, Inc. | Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
US20060025481A1 (en) * | 2004-02-09 | 2006-02-02 | Strange Matthew L | Process for preparation of probucol derivatives and polymorphic forms thereof |
US7294736B2 (en) * | 2004-04-09 | 2007-11-13 | Cambrex Charles City, Inc. | Process for preparation of probucol derivatives |
US20060063828A1 (en) * | 2004-06-28 | 2006-03-23 | Weingarten M D | 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof |
US7345191B2 (en) * | 2005-02-26 | 2008-03-18 | Cambrex Charles City, Inc. | Process for preparation of probucol derivatives |
CN101686676A (zh) * | 2007-03-26 | 2010-03-31 | 沙路特里亚制药有限责任公司 | 用于治疗糖尿病的方法和普罗布考衍生物的组合物 |
US20080280985A1 (en) * | 2007-03-27 | 2008-11-13 | Scott Robert A D | Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes |
WO2008128191A2 (en) * | 2007-04-13 | 2008-10-23 | Chemgenex Pharmaceuticals, Inc. | Oral cephalotaxine dosage forms |
WO2008135984A1 (en) * | 2007-05-03 | 2008-11-13 | Ramot At Tel-Aviv University Ltd. | Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
WO2009006583A1 (en) * | 2007-07-03 | 2009-01-08 | Joslin Diabetes Center, Inc. | Treatment of cardiovascular disease with salicylates |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3875170A (en) * | 1971-05-25 | 1975-04-01 | Banyu Pharma Co Ltd | Pyridine bis (dithiocarbamate) derivatives |
US4025527A (en) * | 1973-07-13 | 1977-05-24 | Smith Kline & French Laboratories Limited | Certain thiazoles and oxazoles |
GB1542840A (en) * | 1975-02-03 | 1979-03-28 | Smith Kline French Lab | Heterocyclic dithiocarbamates and isothioureas |
US4670471A (en) * | 1981-11-03 | 1987-06-02 | Clark Lealand L | Treatment for inflammatory skin disease |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
GB8421039D0 (en) * | 1984-08-17 | 1984-09-19 | Wyeth John & Brother Ltd | Heterocyclic compounds |
EP0228458B2 (en) * | 1985-07-05 | 1997-10-22 | Whitehead Institute For Biomedical Research | Epithelial cells expressing foreign genetic material |
US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
EP0284879A3 (en) * | 1987-03-17 | 1990-10-17 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting interleukin-1 release |
US4870101A (en) * | 1987-03-17 | 1989-09-26 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting interleukin-1 release |
US5035878A (en) * | 1988-09-12 | 1991-07-30 | University Of Rochester | Use of dithiocarbamates to counteract myelosuppression |
US5166133A (en) * | 1991-04-17 | 1992-11-24 | Cetus Corporation | Method for inhibing adhesion of white blood cells to endothelial cells |
AU659482B2 (en) * | 1991-06-28 | 1995-05-18 | Massachusetts Institute Of Technology | Localized oligonucleotide therapy |
FR2679452B1 (fr) * | 1991-07-22 | 1993-11-12 | Cis Bio International | Produit radiopharmaceutique ayant notamment un tropisme cerebral, comportant un complexe nitruro d'un metal de transition, et son procede de preparation. |
US5206264A (en) * | 1991-11-04 | 1993-04-27 | Cypros Pharmaceutical Corporation | Use of disulfiram to prevent cardiovascular damage |
US5306724A (en) * | 1992-08-17 | 1994-04-26 | Clintec Nutrition Company | Method for preventing and treating atherosclerosis |
US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
-
1992
- 1992-10-30 US US07/969,934 patent/US5380747A/en not_active Expired - Lifetime
-
1993
- 1993-11-01 DE DE69326014T patent/DE69326014T2/de not_active Expired - Fee Related
- 1993-11-01 SK SK560-95A patent/SK56095A3/sk unknown
- 1993-11-01 AT AT94902201T patent/ATE183089T1/de not_active IP Right Cessation
- 1993-11-01 DK DK94902201T patent/DK0666741T3/da active
- 1993-11-01 HU HU9501229A patent/HUT73440A/hu unknown
- 1993-11-01 JP JP51138394A patent/JP3254486B2/ja not_active Expired - Fee Related
- 1993-11-01 CZ CZ951115A patent/CZ111595A3/cs unknown
- 1993-11-01 PL PL93308673A patent/PL179113B1/pl unknown
- 1993-11-01 BR BR9307337A patent/BR9307337A/pt not_active Application Discontinuation
- 1993-11-01 ES ES94902201T patent/ES2136186T3/es not_active Expired - Lifetime
- 1993-11-01 WO PCT/US1993/010496 patent/WO1994009772A1/en not_active Application Discontinuation
- 1993-11-01 CA CA002147881A patent/CA2147881C/en not_active Expired - Fee Related
- 1993-11-01 EP EP94902201A patent/EP0666741B1/en not_active Expired - Lifetime
- 1993-11-01 AU AU56653/94A patent/AU692426B2/en not_active Ceased
- 1993-11-01 NZ NZ258683A patent/NZ258683A/xx unknown
-
1995
- 1995-04-27 NO NO951616A patent/NO951616L/no not_active Application Discontinuation
- 1995-04-28 BG BG99604A patent/BG62682B1/bg unknown
-
1996
- 1996-10-17 US US08/722,438 patent/US5877203A/en not_active Expired - Lifetime
-
1999
- 1999-09-29 GR GR990402462T patent/GR3031368T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU692426B2 (en) | 1998-06-11 |
NZ258683A (en) | 1999-08-30 |
HUT73440A (en) | 1996-07-29 |
PL308673A1 (en) | 1995-08-21 |
NO951616D0 (no) | 1995-04-27 |
JPH08506798A (ja) | 1996-07-23 |
SK56095A3 (en) | 1996-06-05 |
NO951616L (no) | 1995-04-27 |
CA2147881C (en) | 1999-09-07 |
ES2136186T3 (es) | 1999-11-16 |
ATE183089T1 (de) | 1999-08-15 |
HU9501229D0 (en) | 1995-06-28 |
PL179113B1 (pl) | 2000-07-31 |
JP3254486B2 (ja) | 2002-02-04 |
AU5665394A (en) | 1994-05-24 |
WO1994009772A1 (en) | 1994-05-11 |
US5877203A (en) | 1999-03-02 |
DK0666741T3 (da) | 1999-12-06 |
EP0666741B1 (en) | 1999-08-11 |
US5380747A (en) | 1995-01-10 |
CZ111595A3 (cs) | 1998-07-15 |
CA2147881A1 (en) | 1994-05-11 |
DE69326014D1 (de) | 1999-09-16 |
BG99604A (bg) | 1996-02-28 |
BG62682B1 (bg) | 2000-05-31 |
DE69326014T2 (de) | 1999-12-23 |
EP0666741A1 (en) | 1995-08-16 |
GR3031368T3 (en) | 2000-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9307337A (pt) | Processo para tratamento de doença cardiovascular e supressão da expressão vcam-1 e composição farmacêutica | |
BG101030A (en) | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases | |
BRPI9917862B8 (pt) | dihidropirimidinas, bem como processo para a preparação e aplicação das mesmas. | |
ATE240940T1 (de) | Arylsulfonanilid-harnstoffe | |
BR9808109A (pt) | Inibidor terapêutico de células vasculares da musculatura lisa | |
ATE280756T1 (de) | Substituierte benzolverbindungen als antiproliferative mittel | |
ATE161273T1 (de) | Polysaccharidderivate von heparin, heparansulfate, ihre fraktionen und fragmente, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, welche diese enthalten | |
NO922634L (no) | Azaoksindol-derivater | |
IT1265101B1 (it) | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico | |
PT1144365E (pt) | Inibidores da adesao de celulas mediada por alfa4beta1 | |
IT1263144B (it) | Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive | |
BR0008310A (pt) | Derivados de alfa-alanina | |
DE69533876D1 (de) | Zusammensetzung für die gentherapeutische Behandlung von Koronar-Arterienerkrankungen. | |
IT1318432B1 (it) | Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro | |
ITMI912309A0 (it) | Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche | |
HUP0000756A2 (hu) | Levobupivakain vagy ropivakain alkalmazása migrén kezelésére alkalmas gyógyszerkészítmények előállítására | |
DE69434424D1 (de) | In vitro kulturprozess für verschiedene stadien von gewebeparasiten | |
MX9304070A (es) | Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol. | |
ATE248845T1 (de) | Arylsulfonanilid-phosphate | |
PL312531A1 (en) | Novel substituted derivatives benzene sulphonylurea and benzene thiosulpholylurea, method of obtaining them, their application in production of pharmaceutic agents and pharmaceutic agent as such | |
PL312530A1 (en) | Novel substituted derivatives benzene sulphonylurea and benzene thiosulpholylurea, method of obtaining them, their application in production of pharmaceutic agents and pharmaceutic agent as such | |
DE69522940D1 (de) | Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren | |
PL312529A1 (en) | Novel substituted derivatives of benzene sulphonylurea or sulphonylthiourea, method of obtaining them, their application in production of pharmaceutic agents and pharmaceutic agent as such | |
ITMI932468A0 (it) | Nuovi difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
IT1255471B (it) | Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
ND | Extension of time allowed | ||
FC | Decision: refusal |